Skip to main content
. 2024 Jul 17;25(5):827–838. doi: 10.1007/s11154-024-09894-w

Table 1.

Main characteristics of SOFT syndrome

Total number of missing data
Gender (Male, M / Female, F) 27 M/ 15F 0
Median (range) age at last investigation reported (years) 7 (0.25–42)
Age at last investigation:
- < 5 years 11/33 (33.5%) 9
- 5–10 years 10/33 (30.5%)
- 10–15 years 4/33 (12%)
- 15–20 years 0/33 (0%)
- > 20 years 8/33 (24%)
Small for gestational age 38/38 (100%) 4
- Median (range) gestational age at birth (weeks) 39 (33–40) 27
- Median (range) birth weight (SDS) -3.1 ([-5.9]-[0]) 15
- Median (range) birth length (SDS) -4 ([-7.1]-[-2]) 18
Relative macrocephaly at birth 31/35 (89%) 7
- Median (range) birth head circumference (SDS) -1.4 ([-3.3]-0) 22
Short stature + Onychodysplasia + Facial dysmorphism + HypoTrichosis 24/42 (57%) 0
Short stature 42/42 (100%) 0
- Median (range) height (SDS) -5.5 ([-8.5]-[-2.8]) 9
- Median (range) adult height (cm) 132.5 (103.5–148) 33
Onychodysplasia 24/42 (57%) 0
Facial dysmorphism 42/42 (100%) 0
- Frontal bossing 40/41 (98%) 1
- Triangular and elongated face 36/41 (92.5%) 1
- Prominent nose 34/41 (83%) 1
- Dolichocephaly 19/41 (46%) 1
- Low-set ears 14/41 (34%) 1
- Hypertelorism 12/41 (29%) 1
- Deep-set eyes 10/41 (24%) 1
HypoTrichosis 31/42(74%) 0
High-pitched voice 19/42 (45%) 0
Muscle cramps 4/42 (9.5%) 0
Metabolic involvement 10/42 (24%)
Metabolic involvement in patients aged over 10 years 9/12 (75%)
- Median (range) BMI (SDS) 23.05 (15–28.57)
- Central distribution of fat 8/42 (19%) 32
- Clinical and/or biological insulin resistance 10/42 (24%)
- Diabetes and/or glucose tolerance abnormalities 7/42 (17%)
- Dyslipidemia 8/42 (19%)
- Hepatic steatosis 8/42 (19%)
Neurological features:
- Normal psychomotor development 29/42 (69%) 0
- Empty or flat sella turcica 3/12 (25%) 30
- Vermian and cerebellar hypotrophy 2/12 (17%) 30
Ophthalmological features 10/16 (62.5%) 26
- Myopia 2/16 (12.5%) 26
- Hypermetropia 3/16 (19%) 26
- Retinopathy 5/16 (31%) 26
Gonadal status
- central precocious puberty F: 3/15 (20%) – M:0/26 (0%)
- PCOS 3/15 (20%)
- Ovarian failure 1/15 (7%)
- Testicular failure 1/26 (4%)
Death 2/42 (5%) 0

The median was used to summarize the continuous quantitative variables with extreme values (range) in parentheses. The frequencies were used to summarize the qualitative variables and were reported as "No. (%)"

F Female, M Male, PCOS polycystic ovary syndrome, SDS standard deviation score